The significant EPS miss is a clear negative signal, but the stock has historically rallied on earnings beats and may have limited downside if the Q2 pre-announcement hints at pipeline progress. Traders should watch for any Q2 guidance or pipeline updates on August 6; a miss there could amplify bearish pressure.
Price Chart
Executive Summary
Denali Therapeutics reported Q1 2026 EPS of -$0.69, a 47.6% miss vs consensus of -$0.47, with revenue of $2.2M in line with estimates. The significant EPS miss and lack of revenue growth or positive catalysts point to operational underperformance, though the company has a history of beating consensus in prior quarters. The stock faces bearish pressure from the earnings miss, but the pre-announcement of Q2 results on August 6 may shift focus to upcoming pipeline updates.
Key Financial Metrics
Key Facts
- Q1 2026 EPS of -$0.69 missed consensus of -$0.47 by 47.6%
- Revenue of $2.2M was in line with consensus estimates
- Company will report Q2 2026 results on August 6, 2026
- Prior four quarters all showed EPS beats vs consensus, making this miss a notable reversal
Financial Impact
EPS miss of $0.22 per share vs consensus, representing a 47.6% negative surprise
Risk Factors
- No revenue growth or positive operational catalysts in Q1
- Potential for continued EPS misses if pipeline development costs remain high without offsetting revenue
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3333848 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $21.57 $20.06 | ▼ −7.00% | ▼ −6.34% | $20.00 (−7.28%) |
Sep 4, 2026 27d ago | Insider Cluster | $22.08 $20.38 | ▼ −7.70% | ▼ −6.58% | $20.00 (−9.42%) |
Aug 6, 2026 8w ago | 8-K | $24.83 $24.40 | ▼ −1.73% | ▼ −2.13% | $20.00 (−19.45%) |
Jul 27, 2026 9w ago | Press Release | $24.05 $23.15 | ▲ +3.74% | ▲ +6.01% | $20.00 (+16.84%) |
Jun 18, 2026 15w ago | 8-K | $23.31 $24.73 | ▲ +6.09% | ▲ +7.76% | $20.00 (−14.20%) |
Jun 18, 2026 15w ago | Press Release | $23.31 $24.73 | ▲ +6.09% | ▲ +7.76% | $20.00 (−14.20%) |
Jun 11, 2026 16w ago | Institutional Cluster | $21.02 $23.49 | ▲ +11.75% | ▲ +11.32% | $20.00 (−4.85%) |
May 21, 2026 19w ago | Press Release | $18.64 $20.41 | ▼ −9.50% | ▼ −7.84% | $20.00 (−7.30%) |
May 7, 2026 21w ago | Press Release | $19.62 $19.39 | ▼ −1.17% | ▼ −2.64% | $20.00 (+1.94%) |
Apr 3, 2026 26w ago | 8-K | $19.38 $19.42 | ▲ +0.21% | ▼ −3.93% | $20.00 (+3.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access